Profile data is unavailable for this security.
About the company
Vistin Pharma ASA is a Norway-based holding company, which operates through its subsidiary Vistin Pharma AS. The Company is engaged in the pharmaceuticals industry. The Company is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
- Revenue in NOK (TTM)438.34m
- Net income in NOK56.23m
- Incorporated2015
- Employees77.00
- LocationVistin Pharma ASAOstensjoveien 27OSLO 0661NorwayNOR
- Phone+47 35984200
- Websitehttps://www.vistin.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncopeptides AB | 35.18m | -248.83m | 610.23m | 57.00 | -- | 6.47 | -- | 17.35 | -1.96 | -1.96 | 0.2776 | 0.4474 | 0.1129 | -- | 1.44 | 617,894.80 | -79.88 | -141.28 | -101.04 | -200.49 | 103.06 | -- | -707.30 | -2,689.06 | -- | -- | 0.7065 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
| Cantargia AB | 0.00 | -279.71m | 670.80m | 22.00 | -- | 3.98 | -- | -- | -1.65 | -1.65 | 0.00 | 0.9186 | 0.00 | -- | -- | 0.00 | -80.18 | -55.08 | -100.27 | -61.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.69 | -- | -- | -- |
| Intellego Technologies AB | 186.28m | 59.54m | 690.97m | 62.00 | 11.26 | 4.57 | 10.96 | 3.71 | 2.33 | 2.33 | 7.35 | 5.74 | 0.8841 | 3.87 | 3.69 | 3,007,968.00 | 28.26 | -- | 44.00 | -- | 68.73 | -- | 31.96 | -- | 2.07 | 5.82 | 0.1684 | -- | 222.74 | -- | 493.56 | -- | -- | -- |
| Alligator Bioscience AB | 55.43m | -248.51m | 691.31m | 55.00 | -- | -- | -- | 12.47 | -0.4848 | -0.4848 | 0.0999 | -0.0772 | 0.5289 | -- | 8.07 | 956,741.40 | -237.13 | -73.26 | -- | -91.33 | -- | -- | -448.35 | -811.68 | -- | -104.20 | -- | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
| Orexo AB | 618.40m | -73.32m | 710.76m | 113.00 | -- | 11.50 | 122.68 | 1.15 | -2.13 | -2.13 | 17.98 | 1.78 | 0.6959 | 1.08 | 2.53 | 5,337,069.00 | -8.25 | -6.41 | -20.27 | -9.99 | 88.14 | 86.76 | -11.86 | -11.83 | 0.589 | 0.1386 | 0.8948 | -- | 2.32 | -3.99 | 27.76 | -- | 25.77 | -- |
| Nightingale Health Oyj | 42.50m | -210.05m | 730.13m | 81.00 | -- | 1.07 | -- | 17.18 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
| IRLAB Therapeutics AB | 5.67m | -157.12m | 763.02m | 28.00 | -- | 9.97 | -- | 134.53 | -3.03 | -3.03 | 0.1095 | 1.48 | 0.0274 | -- | 0.4652 | 218,384.60 | -75.97 | -27.12 | -94.23 | -30.42 | -1,952.47 | -72.18 | -2,770.38 | -155.57 | -- | -- | 0.2646 | -- | -90.71 | 216.07 | -56.82 | -- | -22.56 | -- |
| Moberg Pharma AB (publ) | 0.00 | -21.07m | 774.65m | -- | -- | 1.25 | -- | -- | -1.20 | -1.20 | 0.00 | 21.84 | 0.00 | -- | -- | -- | -3.52 | -- | -3.66 | -- | -- | -- | -- | -- | 3.04 | -- | 0.0077 | -- | -100.00 | -- | -34.26 | -- | -- | -- |
| Vistin Pharma ASA | 438.34m | 56.23m | 975.58m | 77.00 | 17.35 | 3.28 | 13.17 | 2.23 | 1.27 | 1.27 | 9.88 | 6.70 | 1.11 | 2.31 | 7.44 | 5,692,663.00 | 14.28 | 1.73 | 18.93 | 2.11 | 59.93 | 58.92 | 12.83 | 2.36 | 0.8536 | 32.96 | 0.0934 | -- | 51.35 | 16.95 | 1,066.84 | -- | -0.1922 | -- |
| Cereno Scientific AB | 0.00 | -48.05m | 1.00bn | 5.00 | -- | 3.86 | -- | -- | -0.241 | -0.241 | 0.00 | 0.9258 | 0.00 | -- | -- | 0.00 | -19.22 | -16.81 | -20.75 | -18.26 | -- | -- | -- | -- | -- | -12.92 | 0.1734 | -- | -- | -- | -73.95 | -- | 44.79 | -- |
| BioPorto A/S | 50.48m | -83.91m | 1.09bn | 27.00 | -- | 16.80 | -- | 21.65 | -0.1501 | -0.1501 | 0.0903 | 0.1099 | 0.4132 | 3.66 | 7.33 | 1,044,452.00 | -68.68 | -71.10 | -100.20 | -96.55 | 68.08 | 63.38 | -166.23 | -239.22 | 2.36 | -- | 0.1354 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| Diamyd Medical AB | 281.68k | -120.05m | 1.16bn | 26.00 | -- | 6.27 | -- | 4,106.57 | -1.41 | -1.41 | 0.0033 | 1.91 | 0.0014 | -- | 6.56 | 11,280.00 | -59.77 | -25.46 | -66.19 | -28.37 | -4,930.85 | -1,419.23 | -42,617.73 | -5,896.43 | -- | -130.78 | 0.1176 | -- | 20.26 | -5.54 | -12.13 | -- | -- | -- |
| SyntheticMR AB (publ) | 89.11m | 10.00m | 1.17bn | 37.00 | 114.52 | 10.00 | 71.81 | 13.08 | 0.2445 | 0.2445 | 2.17 | 2.80 | 0.6599 | -- | 1.61 | 2,411,162.00 | 7.41 | 7.19 | 8.89 | 8.85 | 105.78 | 106.74 | 11.22 | 9.08 | -- | 14.13 | 0.0107 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 26.79 | -- |
| Arcticzymes Technologies ASA | 117.74m | 16.85m | 1.20bn | 61.00 | 71.18 | 3.81 | 51.60 | 10.15 | 0.3302 | 0.3302 | 2.30 | 6.17 | 0.3562 | 0.4228 | 6.29 | -- | 5.10 | 15.52 | 5.44 | 17.16 | 95.50 | 96.69 | 14.31 | 33.10 | 12.14 | -- | 0.0327 | -- | -13.16 | 12.24 | -43.02 | -- | 47.93 | -- |
| Infant Bacterial Therapeutics AB | 0.00 | -122.93m | 1.25bn | 8.00 | -- | 4.24 | -- | -- | -9.90 | -9.90 | 0.00 | 22.65 | 0.00 | -- | -- | 0.00 | -35.11 | -16.11 | -38.65 | -16.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -88.03 | -- | -- | -- |
Data as of May 16 2024. Currency figures normalised to Vistin Pharma ASA's reporting currency: Norwegian Krone NOK
11.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Holmen Fondsforvaltning ASas of 31 Mar 2023 | 3.52m | 7.94% |
| MP Pensjon PKas of 31 Mar 2023 | 1.72m | 3.88% |
| Atle Investment Services ABas of 30 Jun 2022 | 0.00 | 0.00% |
Data from 30 Jun 2022 - 10 May 2024Source: FactSet Research Systems Inc.
